GPhA PRODS CONGRESS TO MOVE FORWARD WITH BIOGENERICS BILL

Published Online: Thursday, November 1, 2007

Follow Pharmacy_Times:

With time running out
for the 2007 session of
the 110th Congress,
Generic Pharmaceutical
Association (GPhA) leaders
called on lawmakers to step up efforts to enact legislation
that would streamline the approval of lower-cost generic
versions of biological products. ?For the countless
Americans who are in need of safe and affordable lifesaving
biogenerics, it is imperative that Congress continue to move
legislation forward,? GPhA President and Chief Executive
Officer Kathleen Jaeger said during the association?s Annual
Policy Conference in Washington. ?We?ve come a long way in
a short period of time, but we still need to cross the finish
line.?

The bill supported by GPhA has also drawn backing from
more than 70 other organizations that consider it important
to lower the cost of biologicals. If the bill fails to clear the current
Congress before adjournment, the issue could emerge
as a priority for candidates during next fall?s national elections.